Tenoretic 50

   
Google
 
Web NewDrugInformation.com

Tenoretic 50


Drug - Tenoretic 50
The trade name of the product as shown on the labeling.

Dosage - TABLET; ORAL
The product dosage form and route separated by a semi-colon.

Active Ingredient(s) - Atenolol; Chlorthalidone
Multiple ingredients are in alphabetical order.

Strength - 50MG;25MG
The potency of the active ingredient(s), Atenolol; Chlorthalidone. May repeat for multiple part products.

Applicant - ASTRAZENECA
The firm name holding legal responsibility for Tenoretic 50. The firm name is condensed to a maximum twenty character unique string.

New Drug Application (NDA) Number - 018760
The FDA assigned number to Tenoretic 50. Format is nnnnnn.

Product Number - 002
The FDA assigned number to identify Tenoretic 50. Each strength is a separate product. May repeat for multiple part products. Format is nnn.

Therapeutic Equivalence (TE) Code - AB
The TE Code indicates the therapeutic equivalence rating of generic to innovator Rx products.

Approval Date - Jun 8, 1984
The date Tenoretic 50 was approved as stated in the FDA approval letter to the applicant. The format is Mmm dd, yyyy. Products approved prior to the January 1, 1982 contain the phrase: "Approved prior to Jan 1, 1982".

Reference Listed Drug (RLD) - No
The pioneer or innovator of Tenoretic 50. The RLD identifies the product Abbreviated New Drug Applications (ANDA) use as a reference. Format is Yes or No.

Type - RX
The group or category of approved drugs Tenoretic 50 is in. Format is RX, OTC, DISCN.

Applicant Full Name - Astrazeneca Pharmaceuticals Lp
The full name of the firm holding legal responsibility for the new application of Tenoretic 50.

Tenoretic 50